The neuropsychiatry of Parkinson's disease: advances and challenges

D Weintraub, D Aarsland, KR Chaudhuri… - The Lancet …, 2022 - thelancet.com
In people with Parkinson's disease, neuropsychiatric signs and symptoms are common
throughout the disease course. These symptoms can be disabling and as clinically relevant …

Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update

V Voon, TC Napier, MJ Frank… - The Lancet …, 2017 - thelancet.com
Dopaminergic medications used in the treatment of patients with Parkinson's disease are
associated with motor and non-motor behavioural side-effects, such as dyskinesias and …

[HTML][HTML] The role of dopamine in the brain-lessons learned from Parkinson's disease

D Meder, DM Herz, JB Rowe, S Lehéricy, HR Siebner - Neuroimage, 2019 - Elsevier
Parkinson's disease causes a characteristic combination of motor symptoms due to
progressive neurodegeneration of dopaminergic neurons in the substantia nigra pars …

Neurobiology of cue-reactivity, craving, and inhibitory control in non-substance addictive behaviors

S Antons, M Brand, MN Potenza - Journal of the Neurological Sciences, 2020 - Elsevier
Non-substance addictive behaviors may involve repetitive rewarding behaviors including
gambling, gaming, sexual activities, internet-use, and buying-shopping. In addictions, there …

Impulse control disorders in Parkinson's disease. A brief and comprehensive review

EM Gatto, V Aldinio - Frontiers in neurology, 2019 - frontiersin.org
Impulse control and related disorders (ICDs-RD) encompasses a heterogeneous group of
disorders that involve pleasurable behaviors performed repetitively, excessively, and …

Impulse control and related disorders in Parkinson's disease

D Weintraub, DO Claassen - International review of neurobiology, 2017 - Elsevier
Impulse control disorders (ICDs), such as compulsive gambling, buying, sexual, and eating
behaviors, are a serious and increasingly recognized complication in Parkinson's disease …

Dopamine agonists and impulse control disorders: a complex association

M Grall-Bronnec, C Victorri-Vigneau, Y Donnio… - Drug safety, 2018 - Springer
Impulse control disorders (ICDs) are a well-known adverse effect of dopamine agonists
(DAAs). This critical review aims to summarize data on the prevalence and factors …

Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease

KM Smith, SX Xie, D Weintraub - Journal of Neurology, Neurosurgery …, 2016 - jnnp.bmj.com
Objective To describe the incidence of, and clinical and neurobiological risk factors for, new-
onset impulse control disorder (ICD) symptoms and related behaviours in early Parkinson …

[HTML][HTML] Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?

P Yang, JS Perlmutter, TLS Benzinger, JC Morris… - Ageing research …, 2020 - Elsevier
Parkinson disease (PD) is a neurodegenerative disorder characterized by motor and non-
motor symptoms which relentlessly and progressively lead to substantial disability and …

Current drug treatments targeting dopamine D3 receptor

GM Leggio, C Bucolo, CBM Platania… - Pharmacology & …, 2016 - Elsevier
Dopamine receptors (DR) have been extensively studied, but only in recent years they
became object of investigation to elucidate the specific role of different subtypes (D1R, D2R …